SANCUSO is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Kyowa Kirin, Inc.. The primary component is Granisetron.
| Product ID | 42747-726_1623fcfc-ee32-4e20-9e8e-a6767a5c2e13 |
| NDC | 42747-726 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SANCUSO |
| Generic Name | Granisetron |
| Dosage Form | Patch |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2008-09-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022198 |
| Labeler Name | Kyowa Kirin, Inc. |
| Substance Name | GRANISETRON |
| Active Ingredient Strength | 3 mg/24h |
| Pharm Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2008-09-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022198 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-09-12 |
| Ingredient | Strength |
|---|---|
| GRANISETRON | 3.1 mg/24h |
| SPL SET ID: | ba44e7d8-0c71-4eb9-a951-3d91038293c5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42747-726 | SANCUSO | granisetron |
| 66758-035 | Granisetron | Granisetron |
| 66758-036 | Granisetron | Granisetron |
| 47426-101 | SUSTOL | granisetron |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SANCUSO 79064017 3744866 Live/Registered |
Kyowa Kirin, Inc. 2008-12-19 |
![]() SANCUSO 76460343 2814630 Live/Registered |
STRAKAN INTERNATIONAL S.A. 2002-10-17 |